175 related articles for article (PubMed ID: 29518100)
1. Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels.
Nair-Shalliker V; Egger S; Chrzanowska A; Mason R; Waite L; Le Couteur D; Seibel MJ; Handelsman DJ; Cumming R; Smith DP; Armstrong BK
PLoS One; 2018; 13(3):e0193893. PubMed ID: 29518100
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.
Nan H; Kraft P; Hunter DJ; Han J
Int J Cancer; 2009 Aug; 125(4):909-17. PubMed ID: 19384953
[TBL] [Abstract][Full Text] [Related]
3. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.
Muller RL; Gerber L; Moreira DM; Andriole G; Castro-Santamaria R; Freedland SJ
Eur Urol; 2012 Nov; 62(5):757-64. PubMed ID: 22658758
[TBL] [Abstract][Full Text] [Related]
4. Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma.
Duffy DL; Zhao ZZ; Sturm RA; Hayward NK; Martin NG; Montgomery GW
J Invest Dermatol; 2010 Feb; 130(2):520-8. PubMed ID: 19710684
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects.
Kosiniak-Kamysz A; Marczakiewicz-Lustig A; Marcińska M; Skowron M; Wojas-Pelc A; Pośpiech E; Branicki W
Melanoma Res; 2014 Aug; 24(4):388-96. PubMed ID: 24926819
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
Kjaer TN; Ornstrup MJ; Poulsen MM; Jørgensen JO; Hougaard DM; Cohen AS; Neghabat S; Richelsen B; Pedersen SB
Prostate; 2015 Sep; 75(12):1255-63. PubMed ID: 25939591
[TBL] [Abstract][Full Text] [Related]
7. Replication and predictive value of SNPs associated with melanoma and pigmentation traits in a Southern European case-control study.
Stefanaki I; Panagiotou OA; Kodela E; Gogas H; Kypreou KP; Chatzinasiou F; Nikolaou V; Plaka M; Kalfa I; Antoniou C; Ioannidis JP; Evangelou E; Stratigos AJ
PLoS One; 2013; 8(2):e55712. PubMed ID: 23393597
[TBL] [Abstract][Full Text] [Related]
8. MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis.
Ibarrola-Villava M; Hu HH; Guedj M; Fernandez LP; Descamps V; Basset-Seguin N; Bagot M; Benssussan A; Saiag P; Fargnoli MC; Peris K; Aviles JA; Lluch A; Ribas G; Soufir N
Eur J Cancer; 2012 Sep; 48(14):2183-91. PubMed ID: 22464347
[TBL] [Abstract][Full Text] [Related]
9. A closer look at evolution: Variants (SNPs) of genes involved in skin pigmentation, including EXOC2, TYR, TYRP1, and DCT, are associated with 25(OH)D serum concentration.
Saternus R; Pilz S; Gräber S; Kleber M; März W; Vogt T; Reichrath J
Endocrinology; 2015 Jan; 156(1):39-47. PubMed ID: 25396269
[TBL] [Abstract][Full Text] [Related]
10. The relationship between solar UV exposure, serum vitamin D levels and serum prostate-specific antigen levels, in men from New South Wales, Australia: the CHAMP study.
Nair-Shalliker V; Smith DP; Clements M; Naganathan V; Litchfield M; Waite L; Handelsman D; Seibel MJ; Cumming R; Armstrong BK
World J Urol; 2014 Oct; 32(5):1251-7. PubMed ID: 24190367
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population.
Gustafsson O; Norming U; Gustafsson S; Eneroth P; Aström G; Nyman CR
Br J Urol; 1996 Mar; 77(3):433-40. PubMed ID: 8814852
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants associated with skin photosensitivity in a southern European population from Spain.
Hernando B; Sanz-Page E; Pitarch G; Mahiques L; Valcuende-Cavero F; Martinez-Cadenas C
Photodermatol Photoimmunol Photomed; 2018 Nov; 34(6):415-422. PubMed ID: 29974532
[TBL] [Abstract][Full Text] [Related]
13. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y
Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361
[TBL] [Abstract][Full Text] [Related]
14. Association of five SNPs with human hair colour in the Polish population.
Siewierska-Górska A; Sitek A; Żądzińska E; Bartosz G; Strapagiel D
Homo; 2017 Mar; 68(2):134-144. PubMed ID: 28242083
[TBL] [Abstract][Full Text] [Related]
15. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas.
Helsing P; Nymoen DA; Rootwelt H; Vårdal M; Akslen LA; Molven A; Andresen PA
Genes Chromosomes Cancer; 2012 Jul; 51(7):654-61. PubMed ID: 22447455
[TBL] [Abstract][Full Text] [Related]
16. Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
Klaassen Z; Howard LE; Moreira DM; Andriole GL; Terris MK; Freedland SJ
Prostate; 2017 Apr; 77(5):466-470. PubMed ID: 27990661
[TBL] [Abstract][Full Text] [Related]
17. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Bancroft EK; Page EC; Brook MN; Thomas S; Taylor N; Pope J; McHugh J; Jones AB; Karlsson Q; Merson S; Ong KR; Hoffman J; Huber C; Maehle L; Grindedal EM; Stormorken A; Evans DG; Rothwell J; Lalloo F; Brady AF; Bartlett M; Snape K; Hanson H; James P; McKinley J; Mascarenhas L; Syngal S; Ukaegbu C; Side L; Thomas T; Barwell J; Teixeira MR; Izatt L; Suri M; Macrae FA; Poplawski N; Chen-Shtoyerman R; Ahmed M; Musgrave H; Nicolai N; Greenhalgh L; Brewer C; Pachter N; Spigelman AD; Azzabi A; Helfand BT; Halliday D; Buys S; Ramon Y Cajal T; Donaldson A; Cooney KA; Harris M; McGrath J; Davidson R; Taylor A; Cooke P; Myhill K; Hogben M; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Dias A; Dudderidge T; Eccles DM; Green K; Eyfjord J; Falconer A; Foster CS; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Lilja H; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra AV; Moynihan C; Ni Raghallaigh H; Rennert G; Collier R; ; Offman J; Kote-Jarai Z; Eeles RA
Lancet Oncol; 2021 Nov; 22(11):1618-1631. PubMed ID: 34678156
[TBL] [Abstract][Full Text] [Related]
18. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
Gathany AH; Hartge P; Davis S; Cerhan JR; Severson RK; Cozen W; Rothman N; Chanock SJ; Wang SS
Cancer Causes Control; 2009 Oct; 20(8):1291-302. PubMed ID: 19396635
[TBL] [Abstract][Full Text] [Related]
19. Genetics of pigmentation and melanoma predisposition.
Pho LN; Leachman SA
G Ital Dermatol Venereol; 2010 Feb; 145(1):37-45. PubMed ID: 20197744
[TBL] [Abstract][Full Text] [Related]
20. Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk.
Bonilla C; Gilbert R; Kemp JP; Timpson NJ; Evans DM; Donovan JL; Hamdy FC; Neal DE; Fraser WD; Davey SG; Lewis SJ; Lathrop M; Martin RM
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):597-606. PubMed ID: 23441100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
